Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Drug Safety and Availability

Drug Supply Chain Integrity

                        
                FDA Leads Effort to Create a Supply Chain Security Toolkit for Medical Products


                Drug Supply Chain Security Act (DSCSA) Home
          Drugs
          Drug Safety and Availability
          Drug Supply Chain IntegrityDrug Safety and Availability Drug Supply Chain Integrity
  	
        Share
    Post
    Linkedin

    Email
    PrintThe U.S. drug supply chain remains one of the safest in the world. However, the drug supply chain has become increasingly complex as it reaches beyond U.S. borders. Threats to the supply chain such as counterfeiting, diversion, cargo theft, and importation of unapproved or otherwise substandard drugs, could result in unsafe, ineffective drugs in U.S. distribution.

FDA worked with the Asia Pacific Economic Cooperation (APEC) members to create a Supply Chain Security Toolkit for Medical Products to further protect consumers in the global marketplace. This toolkit covers the entire supply chain and lifecycle of medical products. The goal is to enhance global medical product quality and supply chain security.

FDA safeguards the integrity of the drug supply chain through initiatives that help protect consumers from exposure to substandard drugs and ensure that safe and effective drugs reach U.S. consumers. These initiatives include:

BeSafeRx: FDA’s BeSafeRx campaign is designed to educate consumers about the health risks of purchasing prescription medicine through rogue online pharmacies. FDA also issues warning letters to rogue Internet pharmacies and alerts consumers not to purchase medicines from these sites.
	Know Your Source: Protecting Patients from Unsafe Drugs: FDA’s Know Your Source program is designed to educate health care professionals so they can help prevent unsafe or ineffective drugs from reaching their patients by buying the medicines they administer from licensed sources.
	Letters to doctors who may have purchased counterfeit or unapproved prescription drugs: FDA issues letters to health care providers to inform them that they may have obtained counterfeit or unapproved drugs from a rogue distributor. The letters help reduce the public health threat posed by these potentially dangerous drugs and provide tips on safe purchasing practices.See Supply Chain Integrity News for information about recent supply chain issues.

Reporting Suspect Issues to FDA

Product problems should be reported to the FDA when there is a concern about the quality, authenticity, performance, or safety of any medication or device. See examples on how to identify these problems. The following links provide information on how to report these problems to FDA:

The Prescription Drug Marketing Act of 1987 increases safeguards in the drug distribution system to prevent the introduction and retail sale of substandard, ineffective, or counterfeit drugs. Under the law, significant losses, any  theft, and falsification of prescription drug samples should be reported to FDA. FDA requests stakeholders submit these reports via email at PDMAreports@fda.hhs.gov.
	To report product problems, use FDA’s MedWatch Online Voluntary Reporting Forms.
	FDA requests stakeholders report suspected criminal activity.More Information on Drug Supply Chain Integrity

Drug Recalls
	Food and Drug Administration Safety and Innovation Act (FDASIA)
	Standards Development for Prescription Drug Supply Chain SecurityContact Us

Supply chain issues related to drugs and components: DrugSupplyChainIntegrity@fda.hhs.gov
	Track and Trace: DrugTrackandTrace@fda.hhs.gov

                                                                                  Content current as of:
      06/13/2017Drug Supply Chain Integrity                
                          

                        FDA Leads Effort to Create a Supply Chain Security Toolkit for Medical Products


                        Drug Supply Chain Security Act (DSCSA)
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop